Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

Among 26 evaluable patients with clear cell ovarian or endometrial cancer, the objective response rate with the regimen was ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

For the first time, Benjamin Ebert, MD, PhD, the newly appointed president and CEO of Dana-Farber Cancer Institute, moderated ...

NASHVILLE, Tenn. (WTVF) — June is Cancer Immunotherapy Month. Immunotherapy drugs have been on the market for more than a decade. Dr. David Spigel is a medical oncologist at the Sarah Cannon Research ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...